Supply Chain Explorer

Pfizer Inc.

PFE · Large ($10B+)

Moderna, Inc.

MRNA · Mid ($2B–$10B)

Eli Lilly and Company

LLY · Mega ($200B+)

Novo Nordisk

NVO · Mega ($200B+)

Regeneron Pharmaceuticals

REGN · Large ($10B+)

BioNTech SE

BNTX · Mid ($2B–$10B)

Vertex Pharmaceuticals

VRTX · Large ($10B+)

BioMarin Pharmaceutical

BMRN · Mid ($2B–$10B)

Exact Sciences Corporation

EXAS · Mid ($2B–$10B)

Intellia Therapeutics

NTLA · Small (<$2B)

AbbVie Inc.

ABBV · Mega ($200B+)

Amgen Inc.

AMGN · Large ($10B+)

Gilead Sciences, Inc.

GILD · Large ($10B+)

Alnylam Pharmaceuticals, Inc.

ALNY · Mid ($2B–$10B)

CRISPR Therapeutics AG

CRSP · Small (<$2B)

Ionis Pharmaceuticals, Inc.

IONS · Mid ($2B–$10B)

Merck & Co.

MRK · Mega ($200B+)

AstraZeneca

AZN · Mega ($200B+)

Sanofi

SNY · Mega ($200B+)

GSK plc

GSK · Large ($10B+)

Viatris Inc.

VTRS · Mid ($2B–$10B)

Organon & Co.

OGN · Small (<$2B)

Biogen Inc.

BIIB · Large ($10B+)

Incyte Corporation

INCY · Mid ($2B–$10B)

Novartis AG

NVS · Mega ($200B+)